- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 07, 2024, 07:22:18 PM
- Local Time:
- May 29, 2024, 06:17:26 AM
- Last Active:
- May 07, 2024, 09:51:25 PM
Signature:
Zero and also Your five.3% after 52 weeks regarding follow-up. Vedolizumab has been well-tolerated while merely one UC patient enjoyed a serious